Immune determinants of COVID-19 disease presentation and severity
- PMID: 33442016
- DOI: 10.1038/s41591-020-01202-8
Immune determinants of COVID-19 disease presentation and severity
Abstract
COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.
Similar articles
-
Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.Immun Inflamm Dis. 2021 Jun;9(2):331-339. doi: 10.1002/iid3.404. Epub 2021 Feb 10. Immun Inflamm Dis. 2021. PMID: 33566457 Free PMC article. Review.
-
Immunology of SARS-CoV-2 infection in children.Nat Immunol. 2022 Feb;23(2):177-185. doi: 10.1038/s41590-021-01123-9. Epub 2022 Feb 1. Nat Immunol. 2022. PMID: 35105983 Free PMC article. Review.
-
SARS-CoV-2 infections in children: Understanding diverse outcomes.Immunity. 2022 Feb 8;55(2):201-209. doi: 10.1016/j.immuni.2022.01.014. Epub 2022 Jan 20. Immunity. 2022. PMID: 35093190 Free PMC article. Review.
-
The immunology and immunopathology of COVID-19.Science. 2022 Mar 11;375(6585):1122-1127. doi: 10.1126/science.abm8108. Epub 2022 Mar 10. Science. 2022. PMID: 35271343 Review.
-
Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.Pediatr Pulmonol. 2020 Oct;55(10):2556-2564. doi: 10.1002/ppul.24981. Epub 2020 Aug 4. Pediatr Pulmonol. 2020. PMID: 32710693 Review.
Cited by
-
Follow-Up of a Cohort of Patients with Post-Acute COVID-19 Syndrome in a Belgian Family Practice.Viruses. 2022 Sep 9;14(9):2000. doi: 10.3390/v14092000. Viruses. 2022. PMID: 36146806 Free PMC article.
-
Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis.Front Immunol. 2021 May 12;12:657363. doi: 10.3389/fimmu.2021.657363. eCollection 2021. Front Immunol. 2021. PMID: 34054820 Free PMC article.
-
Unmasking Pandemic Echoes: An In-Depth Review of Long COVID's Unabated Cardiovascular Consequences beyond 2020.Diagnostics (Basel). 2023 Nov 2;13(21):3368. doi: 10.3390/diagnostics13213368. Diagnostics (Basel). 2023. PMID: 37958264 Free PMC article. Review.
-
The Relationship between COVID-19 and Innate Immunity in Children: A Review.Children (Basel). 2021 Mar 30;8(4):266. doi: 10.3390/children8040266. Children (Basel). 2021. PMID: 33808490 Free PMC article. Review.
-
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.Pathogens. 2021 May 7;10(5):565. doi: 10.3390/pathogens10050565. Pathogens. 2021. PMID: 34066983 Free PMC article. Review.
References
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous